Product Name: CACYBP Antibody
Species Reactivity: Dog, Human
Tested Applications: ELISA, WB
Applications: CACYBP antibody can be used for detection of CACYBP by ELISA at 1:312500. CACYBP antibody can be used for detection of CACYBP by western blot at 5.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 – 100,000.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 26 kDa, 21 kDa
Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CACYBP.
Host Species: Rabbit
Purification: Antibody is purified by protein A chromatography method.
Physical State: Lyophilized
CAS NO.: 53016-31-2
Product: Norgestimate metabolite Norelgestromin
Buffer: Antibody is lyophilized in PBS buffer with 2% sucrose. Add 100 μL of distilled water. Final antibody concentration is 1 mg/mL.
Concentration: 1 mg/ml
Storage Conditions: For short periods of storage (days) store at 4˚C. For longer periods of storage, store CACYBP antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: CACYBP, GIG5, MGC87971, PNAS-107, RP1-102G20.6, S100A6BP, SIP
Accession NO.: NP_055227
Protein Ino: 7656952
Official Symbol: CACYBP
Geneid: 27101
Background: CACYBP is a calcyclin binding protein. It may be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It probably serves as a molecular bridge in ubiquitin E3 complexes and participates in the ubiquitin-mediated degradation of beta-catenin.The protein encoded by this gene is a calcyclin binding protein. It may be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It probably serves as a molecular bridge in ubiquitin E3 complexes and participates in the ubiquitin-mediated degradation of beta-catenin. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene.
PubMed ID:http://aac.asm.org/content/43/1/25.abstract
